Trump Administration's Tylenol and Autism Announcement Sparks Controversy

White House Announcement on Autism

• 📢 President Trump's administration is reportedly planning a major announcement regarding autism and its potential causes.
• 📰 Reports suggest the administration will warn pregnant women against using Tylenol (acetaminophen) unless they have a high fever.

Expert Pushback and Scientific Evidence

• 🔬 The Autism Science Foundation criticizes the announcement as disingenuous and misleading, stating autism is not reducible to a single cause.
• 📊 Recent studies, including one analyzing 2.5 million children in Sweden, have found no association between Tylenol use during pregnancy and an increased risk of autism, ADHD, or intellectual disabilities.
• ⚠️ Experts caution that failing to treat medical conditions like high fever during pregnancy could pose greater risks to fetal neurodevelopment.

Pharmaceutical Company Response

• 💬 The company owning Tylenol expressed concern about consumer confusion and the impact on expecting mothers, asserting that independent science shows acetaminophen does not cause autism.

Potential Autism Treatments and Causes

• 💊 The administration may also promote lucavorin, a folate-derived drug, as a potential treatment for a subset of autism patients with folate-related defects.
• 📈 Some medical experts suggest the perceived rise in autism cases could be due to improved screening and a broadened definition of autism.